Search

Home > GRACEcast Lung Cancer Video > Can we improve on XALKORI? New agents for patients with an ALK-1 rearrangement
Podcast: GRACEcast Lung Cancer Video
Episode:

Can we improve on XALKORI? New agents for patients with an ALK-1 rearrangement
Category: Science & Medicine
Duration: 00:06:49
Publish Date: 2013-06-19 23:09:09
Description:

Dr. Mary Pinder reviews promising studies from ASCO 2013 on second gen. ALK inhibitors LDK-378, CH5424802, and AP26113 in patients with ALK-positive advanced NSCLC, including impressive activity in crizotinib-refractory patients and those with brain mets.
Total Play: 0